← Super investors
NAMS
Newamsterdam Pharma Company
4 super-investor ownerscombined $379Mlargest position 2.4%
4 of the 83 super-investors we track hold NAMS, worth a combined $379M per their latest 13F filings. The largest position: Stanley Druckenmiller at 2.4% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 39 of 100 (how strongly the cohort backs it) — ranked #137 of 742 stocks.
Why super-investors own NAMS
NAMS is held by 4 super-investors in our cohort, with a combined position value of $379M. The highest-conviction owner is Stanley Druckenmiller at 2.4% of their portfolio.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2022Q4 → 2026Q2How many of the cohort members held this stock each quarter.
Now: 4
Peak: 5
Owners (4) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Viking Global Investors | 0.4% | 15q | $142M | 4,203,567 |
| 2 | Lee Ainslie | 1.0% | 7q | $111M | 3,267,802 |
| 3 | Stanley Druckenmiller | 2.4% | 8q | $104M | 3,070,146 |
| 4 | Joel Greenblatt | <0.1% | 12q | $22M | 645,805 |
Owners of NAMS also hold
Long US equity 13F-HR filings only. CUSIP N62509109. Not investment advice.